Optimization of Antiviral Therapy of Chronic HBV Infection
NCT01623778
·
clinicaltrials.gov ↗
COMPLETED
Status
67
Enrollment
OTHER
Sponsor class
Conditions
Australia Antigen Positive
Hepatitis B
Adverse Effects
Interventions
DRUG:
Interferon Alfa-2a add on ADV
Sponsor
Changhai Hospital